ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OLMA Olema Pharmaceuticals Inc

9.48
-0.35 (-3.56%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Olema Pharmaceuticals Inc OLMA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.35 -3.56% 9.48 19:00:00
Open Price Low Price High Price Close Price Previous Close
9.87 9.51 10.09 9.95 9.83
more quote information »

Recent News

Date Time Source Heading
4/08/202415:30GLOBEOlema Oncology to Participate in Canaccord Genuity 2024..
4/02/202415:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
3/11/202415:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/11/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/202415:05EDGAR2Form 8-K - Current report
3/11/202415:03GLOBEOlema Oncology Reports Fourth Quarter and Full-Year 2023..
3/06/202406:03GLOBEOlema Oncology Announces Publication of Data Highlighting..
3/04/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/29/202413:26EDGAR2Form 144 - Report of proposed sale of securities
2/14/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202411:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/11/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/06/202406:01GLOBEOlema Oncology to Participate in Upcoming Investor..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:30GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
2/01/202414:24EDGAR2Form 144 - Report of proposed sale of securities
1/31/202415:21EDGAR2Form S-3 - Registration statement under Securities Act of..
1/31/202413:58EDGAR2Form 144 - Report of proposed sale of securities
1/29/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202408:07EDGAR2Form 8-K - Current report
1/08/202407:18EDGAR2Form 8-K - Current report
1/08/202407:12GLOBEOlema Oncology Nominates OP-3136, an Orally Bioavailable..
1/05/202416:26EDGAR2Form 8-K - Current report
1/05/202416:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202415:01GLOBEOlema Oncology to Present at 42nd Annual J.P. Morgan..
12/29/202314:54EDGAR2Form 144 - Report of proposed sale of securities
12/18/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202319:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202319:30EDGAR2Form 3/A - Initial statement of beneficial ownership of..
12/06/202306:48EDGAR2Form 8-K - Current report
12/05/202316:15EDGAR2Form 8-K - Current report
12/05/202311:27GLOBEOlema Oncology Announces Palazestrant Demonstrates..
12/04/202315:29GLOBEOlema Oncology Reports Inducement Grants Under Nasdaq..
12/01/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202309:20EDGAR2Form 144 - Report of proposed sale of securities
11/28/202316:10GLOBEOlema Oncology to Present New Palazestrant Clinical Data in..
11/22/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202314:25EDGAR2Form 144 - Report of proposed sale of securities
11/22/202314:04EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock